Scleroza multiplă

1. Dobson R, Dassan P, Roberts M, Giovanonni G, Nelson-Piercy C, Brex PA. UK consensus on pregnancy in multiple sclerosis: ”Association of British Neurologists” Guidelines.Pract Neurol .2019;19:106–114. doi:10.1136/practneurol-2018002060.
2. Coyle PK, Oh J, Magyari M, Oreja-Guevara C, Houtchens M. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Multiple Sclerosis and Related Disorders. 2019;32:54–63. https://doi.org/10.1016/j.msard.2019.04.003.
3. Wynn DR. Enduring Clinical Value of Copaxone (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use. Hindawi Multiple Sclerosis International 2019. Article ID 7151685. 19 pages. https://doi.org/10.1155/2019/7151685
4. Tisovic K, Amezcua L. Women’s Health: Contemporary Management of MS in Pregnancy and Post-Partum. Biomedicines 2019;7:32; doi:10.3390/biomedicines7020032.
5. Zuluaga MI, Otero-Romero S et al. Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis. Neurology. 2019; March; 92 (13): e1507-1516.
6. Fragoso YD, Aldoni T et al. Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children. Neurol Ther.2018;7:207–232. https://doi.org/10.1007/s40120-018-0110-3
7. MacDonald SC, McElrath T, Hernandez-Diaz S. Use and safety of disease‐modifying therapy in pregnant women with multiple sclerosis. Pharmacoepidemiol Drug Saf. 2019;28:556–560.
8. Sandberg-Wollheim M, Neudorfer O et al. Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database. International Journal of MS Care. 2018 Consortium of Multiple Sclerosis Centers. DOI: 10.7224/1537-2073.2016079.
9. Howard J. Multiple sclerosis. Questions and answers for patients and loved ones. DemosHealth USA 2019. ISBN: 9780826177469.
10. Pirko I, Noseworthy JH. Demyelinating Disorders of the Central Nervous System. Textbook of Clinical Neurology. Ediția a 3-a, Chicago, Saunders Elsevier 2007.
11. Harandi AA et al. Vitamine d and Multiple Sclerosis. Iran J Neurol.2014;13(1):1-6.
12. Tsui A, Lee MA. Multiple sclerosis and pregnancy. Current Opinion in Obstetrics and Gynecology. 2011;23 (6):435-439.
13. Sharrack B, Hughes RA. Clinical scales for multiple sclerosis. J Neurol Sci.1996;135(1):1-9.
14. Rojas JI, Patrucco L, Miguez J, Cristiano E. Brain atrophy in multiple sclerosis:therapeutic, cognitive and clinical impact. Arq Neuropsiquiatr. 2016;74(3):235-43.
15. Mihăilescu G. Tratamentul sclerozei multiple. Viața Medicală. 2018; 24 (6): pg 5.
16. Mihăilescu G. Sarcina la femeile cu scleroză multiplă nu este una cu risc crescut. Viața Medicală 2019; 21 (1529): pg8-9.
17. Montalban X et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Eur.J.Neurol.2018;25:215-237.
18. Bajenaru O. Ghiduri de diagnostic și tratament in neurologie. Ed a 2-a. București. Amaltea. 2010.

Material realizat de catre Dr. Gabriela Mihăilescu Medic primar neurolog – Spitalul Clinic Colentina Șef de lucrări – UMF Carol Davila București